Cargando…

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

The CC chemokine ligand 18 (CCL18) is produced by alveolar macrophages in patients with fibrosing lung disease and its concentration is increased in various fibrotic lung diseases. Furthermore CCL18 is elevated in several malignancies as it is produced by tumor associated macrophages. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gkika, Eleni, Vach, Werner, Adebahr, Sonja, Schimeck-Jasch, Tanja, Brenner, Anton, Brunner, Thomas Baptist, Kaier, Klaus, Prasse, Antje, Müller-Quernheim, Joachim, Grosu, Anca-Ligia, Zissel, Gernot, Nestle, Ursula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619767/ https://www.ncbi.nlm.nih.gov/pubmed/28957436 http://dx.doi.org/10.1371/journal.pone.0185350

Ejemplares similares

Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
por: Gkika, Eleni, et al.
Publicado: (2018)

Simultaneous integrated protection: A new concept for high-precision radiation therapy
por: Brunner, Thomas B., et al.
Publicado: (2016)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II
por: Pechkovsky, Dmitri V, et al.
Publicado: (2005)

Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

CC-Chemokine Ligand 18 Induces Epithelial to Mesenchymal Transition in Lung Cancer A549 Cells and Elevates the Invasive Potential
por: Ploenes, Till, et al.
Publicado: (2013)

Serum Level of CC-Chemokine Ligand 18 Is Increased in Patients with Non-Small-Cell Lung Cancer and Correlates with Survival Time in Adenocarcinomas
por: Plönes, Till, et al.
Publicado: (2012)

FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy
por: Carles, Montserrat, et al.
Publicado: (2021)

Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies
por: Gkika, Eleni, et al.
Publicado: (2021)

Lung Collagens Perpetuate Pulmonary Fibrosis via CD204 and M2 Macrophage Activation
por: Stahl, Mirjam, et al.
Publicado: (2013)

Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2015)

Visualization of 4D multimodal imaging data and its applications in radiotherapy planning
por: Schlachter, Matthias, et al.
Publicado: (2017)

A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment
por: Duda, Dan, et al.
Publicado: (2023)

Immunohistochemistry and Radiomic Features for Survival Prediction in Small Cell Lung Cancer
por: Gkika, Eleni, et al.
Publicado: (2020)

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
por: Gkika, Eleni, et al.
Publicado: (2023)

Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis
por: Bettinger, Dominik, et al.
Publicado: (2018)

The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
por: Gkika, Eleni, et al.
Publicado: (2020)

Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer—A Secondary Analysis of the PET Plan Trial
por: Gkika, Eleni, et al.
Publicado: (2020)

Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10
por: Murakami, Takashi, et al.
Publicado: (2003)

User Interaction in Semi-Automatic Segmentation of Organs at Risk: a Case Study in Radiotherapy
por: Ramkumar, Anjana, et al.
Publicado: (2015)

Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
por: Korbecki, Jan, et al.
Publicado: (2020)

Patient reported outcomes based on EQ-5D-5L questionnaires in head and neck cancer patients: a real-world study
por: Sprave, Tanja, et al.
Publicado: (2022)

Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) – protocol of a randomized phase II trial (NOA 10/ARO 2013-1)
por: Oehlke, Oliver, et al.
Publicado: (2016)

The Role of CC-Chemokines in the Regulation of Angiogenesis
por: Ridiandries, Anisyah, et al.
Publicado: (2016)

The roles of CC chemokines in response to radiation
por: Wang, Lei, et al.
Publicado: (2022)

Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours
por: Scotton, C, et al.
Publicado: (2001)

Roflumilast-N-oxide Induces Surfactant Protein Expression in Human Alveolar Epithelial Cells Type II
por: Höhne, Kerstin, et al.
Publicado: (2012)

Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist
por: Isaikina, Polina, et al.
Publicado: (2021)

Bronchoalveolar Lavage Fluid Reflects a T(H)1-CD21(low) B-Cell Interaction in CVID-Related Interstitial Lung Disease
por: Friedmann, David, et al.
Publicado: (2021)

CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors
por: Santoni, Matteo, et al.
Publicado: (2014)

Selected CC and CXC chemokines in children with atopic asthma
por: Machura, Edyta, et al.
Publicado: (2016)

Role of CC-chemokine ligand 2 in gynecological cancer
por: Zhang, Jia-Jia, et al.
Publicado: (2022)

Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8
por: Sun, Dawei, et al.
Publicado: (2023)

Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study
por: Gkika, Eleni, et al.
Publicado: (2022)

Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) – protocol for a multi-center, single-arm phase IIa trial
por: Frye, Björn C., et al.
Publicado: (2020)

The role of CC-chemokine receptor 4 in murine polymicrobial sepsis
por: Maier, Stefan, et al.
Publicado: (2007)

Study of CC chemokine receptor 5 in renal allograft rejection
por: Ghosh, R., et al.
Publicado: (2013)

CC Chemokine Receptor 5: The Interface of Host Immunity and Cancer
por: de Oliveira, Carlos Eduardo Coral, et al.
Publicado: (2014)

Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists
por: Zheng, Yi, et al.
Publicado: (2016)

CC chemokines and receptors in osteoarthritis: new insights and potential targets
por: Zhang, Yuchen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_15snkooom0f8nvcj7kahsuo64o